Home Mf Research Motilal Oswal Bse Healthcare Etf Regular Plan
MOTILAL OSWAL MUTUAL FUND

Motilal Oswal BSE Healthcare ETF - REGULAR PLAN

Others Solution Oriented Index
Fund House : MOTILAL OSWAL MUTUAL FUND
Overview
Returns
Portfolio
SIP Calculator
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI
NAV (as on 2025-06-13)
44.40 0.08%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
0.22%
Expense Ratio (Direct)
-%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-06-06 ₹1,000.00 ₹1,017.81
1.78 %
Two Week 2025-05-29 ₹1,000.00 ₹1,029.98
3.00 %
One Month 2025-05-14 ₹1,000.00 ₹1,040.90
4.09 %
Three Months 2025-03-17 ₹3,000.00 ₹3,207.93
6.93 %
Six Months 2024-12-16 ₹6,000.00 ₹6,342.82
5.71 %
One Year 2024-06-13 ₹12,000.00 ₹12,730.30
6.09 %
Since Inception 2022-07-29 ₹36,000.00 ₹52,570.84
46.03 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceutical Industries Limited - Equity 100.00
Divi's Laboratories Limited - Equity 200.00
Max Healthcare Institute Limited - Equity 300.00
Cipla Limited - Equity 400.00
Dr. Reddy's Laboratories Limited - Equity 500.00
Apollo Hospitals Enterprise Limited - Equity 600.00
Lupin Limited - Equity 700.00
Fortis Healthcare Limited - Equity 800.00
Torrent Pharmaceuticals Limited - Equity 900.00
Aurobindo Pharma Limited - Equity 1,000.00
Mankind Pharma Limited - Equity 1,100.00
Alkem Laboratories Limited - Equity 1,200.00
Laurus Labs Limited - Equity 1,300.00
Zydus Lifesciences Limited - Equity 1,400.00
Glenmark Pharmaceuticals Limited - Equity 1,500.00
IPCA Laboratories Limited - Equity 1,600.00
Krishna Institute Of Medical Sciences Limited - Equity 1,700.00
Abbott India Limited - Equity 1,800.00
Biocon Limited - Equity 1,900.00
GlaxoSmithKline Pharmaceuticals Limited - Equity 2,000.00
Cohance Lifesciences Limited - Equity 2,100.00
Aster DM Healthcare Limited - Equity 2,200.00
Piramal Pharma Limited - Equity 2,300.00
Gland Pharma Limited - Equity 2,400.00
Syngene International Limited - Equity 2,500.00
Wockhardt Limited - Equity 2,600.00
JB Chemicals & Pharmaceuticals Limited - Equity 2,700.00
Narayana Hrudayalaya Limited - Equity 2,800.00
Ajanta Pharma Limited - Equity 2,900.00
Dr. Lal Path Labs Limited - Equity 3,000.00
Concord Biotech Limited - Equity 3,100.00
Global Health Limited - Equity 3,200.00
Neuland Laboratories Limited - Equity 3,300.00
Jubilant Pharmova Limited - Equity 3,400.00
Poly Medicure Limited - Equity 3,500.00
Pfizer Limited - Equity 3,600.00
Natco Pharma Limited - Equity 3,700.00
Granules India Limited - Equity 3,800.00
Rainbow Childrens Medicare Limited - Equity 3,900.00
Eris Lifesciences Limited - Equity 4,000.00
Acutaas Chemicals Limited - Equity 4,100.00
Alembic Pharmaceuticals Limited - Equity 4,200.00
Sanofi India Limited - Equity 4,300.00
Strides Pharma Science Limited - Equity 4,400.00
Jupiter Life Line Hospitals Limited - Equity 4,500.00
Marksans Pharma Limited - Equity 4,600.00
AstraZeneca Pharma India Limited - Equity 4,700.00
Shilpa Medicare Limited - Equity 4,800.00
Sanofi Consumer Healthcare India Limited - Equity 4,900.00
Procter & Gamble Health Limited - Equity 5,000.00
Indegene Limited - Equity 5,100.00
Aarti Pharmalabs Limited - Equity 5,200.00
Vijaya Diagnostic Centre Limited - Equity 5,300.00
Caplin Point Laboratories Limited - Equity 5,400.00
Metropolis Healthcare Limited - Equity 5,500.00
Sai Life Sciences Limited - Equity 5,600.00
Alivus Life Sciences Limited - Equity 5,700.00
Kovai Medical Center and Hospital Limited - Equity 5,800.00
Emcure Pharmaceuticals Limited - Equity 5,900.00
Morepen Laboratories Limited - Equity 6,000.00
Sequent Scientific Limited - Equity 6,100.00
Blue Jet Healthcare Ltd - Equity 6,200.00
Healthcare Global Enterprises Limited - Equity 6,300.00
FDC Limited - Equity 6,400.00
Indraprastha Medical Corporation Limited - Equity 6,500.00
Yatharth Hospital And Trauma Care Services Limited - Equity 6,600.00
Supriya Lifescience Limited - Equity 6,700.00
Sun Pharma Advanced Research Company Limited - Equity 6,800.00
Dishman Carbogen Amcis Limited - Equity 6,900.00
Thyrocare Technologies Limited - Equity 7,000.00
Aarti Drugs Limited - Equity 7,100.00
Akums Drugs and Pharmaceuticals Limited - Equity 7,200.00
Suven Life Sciences Limited - Equity 7,300.00
Solara Active Pharma Sciences Limited - Equity 7,400.00
Advanced Enzyme Technologies Limited - Equity 7,500.00
Hikal Limited - Equity 7,600.00
Innova Captab Limited - Equity 7,700.00
Unichem Laboratories Limited - Equity 7,800.00
Krsnaa Diagnostics Limited - Equity 7,900.00
Gufic Biosciences Limited - Equity 8,000.00
Syncom Formulations India Limited - Equity 8,100.00
IOL Chemicals and Pharmaceuticals Limited - Equity 8,200.00
Gujarat Themis Biosyn Limited - Equity 8,300.00
Sigachi Industries Limited - Equity 8,400.00
Orchid Pharma Limited - Equity 8,500.00
RPG Life Sciences Limited - Equity 8,600.00
Indoco Remedies Limited - Equity 8,700.00
Bliss GVS Pharma Limited - Equity 8,800.00
Artemis Medicare Services Limited - Equity 8,900.00
SMS Pharmaceuticals Limited - Equity 9,000.00
Vimta Labs Limited - Equity 9,100.00
Windlas Biotech Limited - Equity 9,200.00
Novartis India Limited - Equity 9,300.00
Hester Biosciences Limited - Equity 9,400.00
Tarsons Products Limited - Equity 9,500.00
Lincoln Pharmaceuticals Limited - Equity 9,600.00
Shalby Limited - Equity 9,700.00
Kopran Limited - Equity 9,800.00
Suraksha Diagnostic Limited - Equity 9,900.00
GPT Healthcare Limited - Equity 10,000.00
Senores Pharmaceuticals Limited - Equity 10,100.00
Themis Medicare Limited - Equity 10,200.00
KMC Speciality Hospitals (India) Limited - Equity 10,300.00
Sastasundar Ventures Limited - Equity 10,400.00
NGL Fine Chem Limited - Equity 10,500.00
SIP Calculator
Risk Ratios
Standard Deviation
-
Beta
-
Sharpe Ratio
-
Lock In Period
-
Residual Maturity
-
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : Mr. Swapnil Mayekar (more than 13 years), Mr. Rakesh Shetty (more than 14 years),
  • Expense ration regular : 0.22
  • Expense ration direct : -
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹100.00
  • Type : others
Exit load
NIL

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?